Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Collegium Pharmaceutical (COLL) Shares Repurchased (2021 - 2024)

Collegium Pharmaceutical (COLL) has 3 years of Shares Repurchased data on record, last reported at $25.0 million in Q4 2024.

  • For Q4 2024, Shares Repurchased changed N/A year-over-year to $25.0 million; the TTM value through Dec 2025 reached $25.0 million, down 79.02%, while the annual FY2025 figure was $25.1 million, 58.18% down from the prior year.
  • Shares Repurchased reached $25.0 million in Q4 2024 per COLL's latest filing, down from $61.9 million in the prior quarter.
  • Across five years, Shares Repurchased topped out at $61.9 million in Q4 2022 and bottomed at $25.0 million in Q4 2024.
  • Average Shares Repurchased over 3 years is $39.8 million, with a median of $32.3 million recorded in 2021.
  • The widest YoY moves for Shares Repurchased: up 91.5% in 2022, down 91.5% in 2022.
  • A 3-year view of Shares Repurchased shows it stood at $32.3 million in 2021, then surged by 91.5% to $61.9 million in 2022, then tumbled by 59.59% to $25.0 million in 2024.
  • Per Business Quant database, its latest 3 readings for Shares Repurchased were $25.0 million in Q4 2024, $61.9 million in Q4 2022, and $32.3 million in Q4 2021.